Govt to ensure regulatory facilitation for Serum's Covid-19 vaccine trials

Serum Institute of India, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

India will ensure regulatory facilitation and actively consider supplementing resources for expediting the Serum Institute of India's phase 3 trial of a vaccine for Covid-19 developed by Oxford University.

With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) had on Monday said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.

SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.

Asked if the